Approvals/TGA/IRINOTECAN APOTEX irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection via

Approved

STANDARD

IRINOTECAN APOTEX irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection via

Baxter Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ff64769655bd706a
Product Name: IRINOTECAN APOTEX irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection via
Artg Id: 246739
Artg Name: IRINOTECAN APOTEX irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Sponsor: Baxter Healthcare Pty Ltd
Company Detail Path: /organization/baxter-healthcare-pty-ltd
Artg Date: 2016-05-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ff64769655bd706a

Type

Standard